Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CSPC Pharmaceutical Group...

    OTC: CHJTF · Real-Time Price · USD
    1.27
    0.00 (0.00%)
    At close: Aug 05, 2025, 12:35 PM
    1.27
    0.00%
    After-hours: Aug 13, 2025, 08:00 PM EDT

    CSPC Pharmaceutical Income Statement

    Financials in HKD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 41.89B 32.42B 40.47B 41.06B 52.13B 61.1B 53.05B 52.43B 47.72B 44.61B
    Cost of Revenue
    		 11.99B 9.32B 11.86B 12.02B 14.95B 16.8B 14.26B 13.27B 11.67B 10.99B
    Gross Profit
    		 29.9B 23.09B 28.61B 29.04B 37.18B 44.3B 38.78B 39.16B 36.05B 33.62B
    Operating Income
    		 9.71B 7.64B 9.38B 9.31B 11.56B 13.45B 11.7B 11.71B 10.86B 9.85B
    Interest Income
    		 145.93M 287.08M 287.08M 302.79M 421.7M 411.55M 411.55M 339.91M 308.39M 206.58M
    Pretax Income
    		 10.06B 7.87B 9.65B 9.96B 12.52B 14.45B 12.67B 12.71B 12.19B 11.57B
    Net Income
    		 7.91B 6.21B 7.63B 8B 10.06B 11.59B 10.17B 10.33B 10.01B 9.48B
    Selling & General & Admin
    		 10.71B 7.58B 10.33B 10.41B 15.19B 19.35B 16.6B 21.04B 19.41B 18.59B
    Research & Development
    		 6.84B 5.4B 6.41B 6.04B 6.94B 7.84B 6.84B 6.41B 5.78B 5.18B
    Other Expenses
    		 138.72M 138.72M 155.37M 525.52M 388.58M 388.58M 371.94M n/a n/a n/a
    Operating Expenses
    		 20.34B 15.81B 19.59B 20.09B 25.83B 30.85B 27.08B 27.45B 25.19B 23.78B
    Interest Expense
    		 15.17M 21.47M 25.9M 33.9M 39.48M 36.68M 32.25M 20.97M 16.87M 19.51M
    Selling & Marketing Expenses
    		 9.37B 6.65B 9.14B 9.26B 7.13B 4.71B 2.22B n/a n/a n/a
    Cost & Expenses
    		 32.33B 25.14B 31.45B 32.11B 40.77B 47.65B 41.34B 40.72B 36.86B 34.76B
    Income Tax Expense
    		 1.9B 1.4B 1.71B 1.7B 2.2B 2.62B 2.31B 2.23B 2.08B 1.97B
    Shares Outstanding (Basic)
    		 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.95B
    Shares Outstanding (Diluted)
    		 11.84B 11.85B 11.85B 11.88B 11.89B 11.92B 11.93B 11.92B 11.95B 11.96B
    EPS (Basic)
    		 0.80 0.81 0.79 0.82 0.99 0.97 0.85 0.87 0.84 0.79
    EPS (Diluted)
    		 0.80 0.81 0.79 0.82 0.99 0.97 0.85 0.87 0.84 0.79
    EBITDA
    		 10.93B 8.27B 10.05B 9.99B 12.82B 15.23B 13.44B 13.33B 12.45B 11.34B
    EBIT
    		 7.7B 5.63B 7.38B 7.58B 7.61B 9.57B 7.83B 9.55B 11.06B 9.99B
    Depreciation & Amortization
    		 1.22B 1.23B 1.27B 1.27B 1.85B 1.78B 1.74B 1.62B 1.52B 1.42B

    Add to Watchlist